Pasithea Therapeutics Cash Flow Statement (2021-2024) | KTTA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Operating Activities
Net Income (Quarter) -0.55M-0.73M-1.53M0.63M-0.33M-0.47M-0.40M-1.06M-0.27M-0.17M-0.02M-3.86M-3.87M-3.00M-3.18M
Depreciation and Depletion (Quarter) 0.01M-0.00M-1.000.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M
Share-based Compensation (Quarter) 0.30M-0.27M0.72M0.14M0.10M0.11M0.16M0.18M0.20M0.10M0.07M0.07M0.00M0.00M0.12M
Cash from Discontinued Operations (Quarter) -0.41M0.01M-0.63M-0.77M-0.18M-0.40M-0.01M-0.02M
Gains from Sales and Divestitures (Quarter) 0.10M0.01M
Gains from Investment Securities (Quarter) 0.25M-2.59M0.60M0.40M0.34M-2.26M960.000.88M-0.04M-0.06M-0.03M0.04M0.02M-0.00M
Non-cash Items (Quarter) 0.10M0.10M0.10M0.25M0.01M0.85M0.06M0.10M0.10M0.10M
Cash from Operations (Quarter) -0.38M-0.50M-0.55M-1.74M-2.15M-1.94M-4.62M-3.19M-3.20M-3.08M-3.24M-3.29M-4.32M-4.04M-3.12M-2.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.16M0.16M0.16M0.16M0.16M0.16M0.16M0.16M
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M
Change in Working Capital
Change in Account Payables (Quarter) -0.02M
Change in Accured Expenses (Quarter) 0.23M0.22M0.07M-0.08M0.03M0.03M0.41M0.28M-0.03M0.47M-0.05M0.68M-0.12M-1.04M-0.76M0.48M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.00M0.01M0.01M0.09M0.05M0.00M-0.02M-36.00
Sales of Property, Plant and Equipment (Quarter) 0.03M0.05M
Acquisitions (Quarter) 0.02M2.25M
Divestments (Quarter) -0.11M-0.43M-0.16M0.07M0.00M0.32M
Cash from Investing Activities (Quarter) -0.01M-0.00M0.07M-0.03M-2.34M-0.05M0.02M0.05M0.05M
Financing Activities
Other financing activities (Quarter) 0.30M0.01M-0.84M0.03M0.02M0.02M-0.07M0.02M0.02M0.02M-0.46M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 1.21M20.65M5.30M0.39M
Long-Term Debt Repayments (Quarter) 0.13M0.13M0.13M
Change in Capital Stock
Shares Issued (Quarter) 5.79M4.50M-0.48M
Misc.
Cash from Financing Activities (Quarter) 1.21M20.55M34.17M0.26M-0.13M-3.86M-0.02M
Exchange Rate Effect (Quarter) -0.00M-0.01M-0.00M-0.04M-0.08M0.14M-0.00M-317.00-0.00M0.00M-620.00-0.00M-0.03M0.03M
Change in Cash (Quarter) 0.83M-0.50M20.00M32.40M-2.68M-2.33M-5.52M-9.29M-3.17M-3.27M-7.06M-3.25M-4.32M-4.04M1.39M-2.44M
Free Cash Flow (Quarter) -0.38M-0.50M-0.55M-1.76M-2.15M-1.94M-4.63M-3.28M-3.26M-3.08M-3.22M-3.29M-4.32M-4.04M-3.12M-2.44M
Net Cash Flow (Quarter) 0.83M-0.50M20.01M32.41M-2.15M-1.87M-4.65M-5.53M-2.99M-3.19M-7.05M-3.24M-4.32M-4.04M-3.12M-2.47M